Pulmonary Arterial Hypertension (PAH) - Epidemiology Forecast to 2023

  • ID: 4300726
  • Report
  • 40 pages
  • DelveInsight
1 of 3
“Pulmonary Arterial Hypertension (PAH) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Pulmonary Arterial Hypertension (PAH) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Pulmonary Arterial Hypertension (PAH) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Pulmonary Arterial Hypertension (PAH). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by our team of industry experts.

Please Note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report:
- The Report includes the prevalent population and how will it change over the next eight years.
- Prevalent or incident cases segmented by age and sex.
- Coverage of key Pulmonary Arterial Hypertension (PAH) subpopulations and its prevalent or incident cases
- The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits:
- The report will help in developing business strategies by understanding the trends shaping and driving the global Pulmonary Arterial Hypertension (PAH) market.
- Identifying prevalent patient populations as well as risk factors in the global Pulmonary Arterial Hypertension (PAH) market will help to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension (PAH) therapeutics in each of the markets covered.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Pulmonary Arterial Hypertension (PAH)Overview
Pulmonary Arterial Hypertension (PAH) Definition
Pathophysiology
Symptoms
Etiology
5. Risk Factors Associated with Pulmonary Arterial Hypertension (PAH)
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2013-2023
Prevalent & Incident Cases by Category-2013-2023
- Age-Specific Prevalent/ Incident Cases of Pulmonary Arterial Hypertension (PAH)
- Sex-Specific Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
- Disease Type Specific Prevalent/Incident Cases of Pulmonary Arterial Hypertension (PAH)
Prevalent & Incident Cases by 7 MM-2013-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of United States-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of United Kingdom-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of Germany-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of France-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of Spain-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of Italy-2023
- Pulmonary Arterial Hypertension (PAH) Epidemiology of Japan-2023
8. Key Takeaways
9. Appendix
10. Report Methodology
11. Consulting Services
12. Disclaimer
13. About Us

List of Tables
Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Pulmonary Arterial Hypertension (PAH) Global Epidemiology, (2013-2023)
Table 6: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), US (2013-2023)
Table 7: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), US (2013-2023)
Table 8: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, US (2013-2023)
Table 9: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), United Kingdom (2013-2023)
Table 10: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), United Kingdom (2013-2023)
Table 11: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, United Kingdom (2013-2023)
Table 12: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Germany (2013-2023)
Table 13: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Germany (2013-2023)
Table 14: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, Germany (2013-2023)
Table 15: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), France (2013-2023)
Table 16: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), France (2013-2023)
Table 17: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, France (2013-2023)
Table 18: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Italy (2013-2023)
Table 19: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Italy (2013-2023)
Table 20: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, Italy (2013-2023)
Table 21: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Spain (2013-2023)
Table 22: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Spain (2013-2023)
Table 23: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, Spain (2013-2023)
Table 24: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Japan (2013-2023)
Table 25: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Japan (2013-2023)
Table 26: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population, Japan (2013-2023)

List of Figures
Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Pulmonary Arterial Hypertension (PAH) Global Epidemiology, (2013-2023)
Figure 4: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), US (2013-2023)
Figure 5: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), US (2013-2023)
Figure 6: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,US (2013-2023)
Figure 7: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), United Kingdom (2013-2023)
Figure 8: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), United Kingdom (2013-2023)
Figure 9: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,United Kingdom (2013-2023)
Figure 10: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Germany (2013-2023)
Figure 11: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Germany (2013-2023)
Figure 12: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,Germany (2013-2023)
Figure 13: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), France (2013-2023)
Figure 14: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), France (2013-2023)
Figure 15: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,France (2013-2023)
Figure 16: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Italy (2013-2023)
Figure 17: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Italy (2013-2023)
Figure 18: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,Italy (2013-2023)
Figure 19: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Spain (2013-2023)
Figure 20: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Spain (2013-2023)
Figure 21: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,Spain (2013-2023)
Figure 22: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) (Ages = XX Years), Japan (2013-2023)
Figure 23: Prevalent Cases of Pulmonary Arterial Hypertension (PAH) By Sex (Males & Females), Japan (2013-2023)
Figure 24: Prevalent Cases By Pulmonary Arterial Hypertension (PAH) Sub-population,Japan (2013-2023)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll